← Back to all signals
RESEARCH PAPER ANALYSIS

Global research trends and hotspots in the health effects of Tai Chi on older adults: a bibliometric analysis (2010-2025).

A bibliometric analysis of 2,532 publications (2010–2025) on Tai Chi and older adults showing growth in research with major clusters in balance, quality of life, depression, and cognition and an emergent, but superficial, link to Parkinson's disease.

PMID41952826
JournalFrontiers in public health
Publication Date2026-01-01
Ingested2026-04-28 08:58 PM
EXECUTIVE SUMMARY

What the AI sees

A bibliometric analysis of 2,532 publications (2010–2025) on Tai Chi and older adults showing growth in research with major clusters in balance, quality of life, depression, and cognition and an emergent, but superficial, link to Parkinson's disease.

WHY IT MATTERS

Research significance

While offering little mechanistic or therapeutic insight for Parkinson's drug discovery, the paper highlights growing interest in Tai Chi as a nonpharmacologic intervention relevant to PD rehabilitation and flags Parkinson's disease as an emerging clinical application worth mechanistic follow-up.

ABSTRACT

Source abstract

INTRODUCTION: Tai Chi has potential benefits in promoting healthy aging, but a comprehensive understanding of its global research landscape, thematic evolution, and emerging trends remains limited. This study aims to use bibliometric methods to systematically analyze the knowledge structure, hotspot evolution, and collaborative networks of global research on Tai Chi and the health of the older adult(s) from 2010 to 2025, in order to explore future research hotspots and trends. METHODS: A bibliometric approach was employed to conduct a visualized analysis of 2,532 eligible publications retrieved from the Web of Science (WOS) and Scopus databases. VOSviewer and CiteSpace software were used to examine publication trends, collaborative patterns, keyword co-occurrence, and thematic evolution. RESULTS: The number of publications increased from approximately 80 in 2010 to a peak of about 270 in 2025, indicating that the field has entered a phase of accelerated development. China (1,034 publications, 41%) and the United States (865 publications, 34%) constituted the dual core of global research output. Institutions such as Shanghai University of Sport (52 publications) and Harvard University (38 publications) formed key cross-regional collaborative networks. Keyword co-occurrence analysis identified four major research clusters: balance and fall prevention (175 occurrences), quality of life (127 occurrences), depression (103 occurrences), and cognitive function. Burst keyword analysis revealed that the research frontier has shifted from "alternative medicine" toward "Parkinson's disease" (burst strength = 3.66) and "network meta-analysis" (burst strength = 8.37). CONCLUSION: Research on Tai Chi has been deeply integrated into the modern rehabilitation medicine system, with the research paradigm shifting from single functional outcome validation toward multidimensional health promotion and precision evidence-based approaches encompassing physical, psychological, and cognitive domains. This study supports the inclusion of Tai Chi as a low-cost, high-efficiency mind-body intervention model within global strategies for promoting healthy aging.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 The cGAS-STING-Glymphatic-gut Axis in Parkinson's disease: A proposed self-amplifying triad of Neuroinflammation and therapeutic opportunity. International immunopharmacology 91.0 2 Immunosenescence and Inflammaging as Drivers of Neurodegeneration: Cellular Mechanisms, Neuroimmune Crosstalk, and Therapeutic Implications. Cells 91.0 3 Flavonoids improve neurotransmitters for Parkinson's treatment: mechanism and therapeutic potential. Frontiers in pharmacology 88.0 4 Alpha-Lipoic Acid and Biotin in Neurodegenerative Diseases: Convergent Mechanistic Insights from Preclinical Models to Clinical Perspectives. Neurology international 78.0 5 The Gut Microbiota in Parkinson's Disease: Mechanistic Insights into Microbial-Host Interactions. Microorganisms 85.0 6 Linking inflammation, metabolic dysfunction, and neurodegeneration: a comprehensive review of TLR2 pathways in type 2 diabetes. Frontiers in clinical diabetes and healthcare 80.0 7 Neuroprotective effects of GLP-2 and a GLP-2/GIP dual receptor agonist in an MPTP-induced mouse model of Parkinson's disease. Peptides 86.0 8 TNF alpha unmasks enteric malate aspartate shuttle dysfunction bridging Parkinson disease and intestinal inflammation. Nature communications 91.5 9 Lipid Metabolism and Neurodegeneration: Mechanistic Insights and Therapeutic Targets. Ageing research reviews 82.0 10 Shared functional microbiome signatures in Parkinson's disease and constipation predominate irritable bowel syndrome despite taxonomic divergence. Brain, behavior, & immunity - health 80.0 11 Benzimidazole as a Versatile Scaffold for Developing Neurotherapeutics Against Neurodegenerative Diseases. ChemMedChem 74.0 12 Biomimicking neuromelanin reverses the gait deficits and dopaminergic neuronal loss in the Parkinson's disease. Colloids and surfaces. B, Biointerfaces 86.0 13 Neuroprotective roles of klotho: Molecular pathways and therapeutic implications for cognitive health in neurological and psychiatric diseases. Experimental physiology 84.0 14 Flavonoid Rutin Reduces Intestinal Inflammation in an Experimental Model of Parkinson's Disease. Neurotoxicity research 70.0 15 Nanostructured Lipid Carriers Enhance Brain Delivery and Antioxidant Efficacy of a Small-Molecule MAO B Inhibitor for Neurodegenerative Disease Therapy. Molecular pharmaceutics 78.0 16 Pathophysiological Role of the Gut Brain Axis in Parkinson's Disease: From Microbial Metabolites and Intestinal Permeability to Central Neuroinflammation. Current neurovascular research 86.0 17 Parkinson's Disease: From Metabolism to Genetics-A Comprehensive Review. Current issues in molecular biology 86.0 18 Navigating the cholesterol maze: Key insights on use of statins in neurodegenerative disorders. Neuroprotection (Chichester, England) 76.0 19 Integrative network pharmacology delineates dual GPCR and non-GPCR mechanisms of blended and individual Taikong Blue lavender and Pingyin rose essential oils in neurodegenerative and psychiatric disorders. Computers in biology and medicine 65.0 20 Models of neuroprotection in Parkinson's disease: Exploring cellular, molecular, and microenvironmental targets. Experimental neurology 78.0 21 Hyaluronic acid: emerging roles and biomaterial innovations in Alzheimer's and Parkinson's disease therapy. Frontiers in pharmacology 75.2 22 Molecular mechanisms underlying Parkinson's disease and role of phytochemicals, α-synuclein, sirtuins, and incretin mimetics in potential therapy. Frontiers in pharmacology 75.0 23 Lipid droplets in neurodegenerative diseases: pathological drivers and therapeutic vulnerabilities. Cell death discovery 82.0 24 Brain-gut-microbiota axis: a review on the bidirectional regulatory mechanisms between gut microbiota and brain and their disease interactions. Frontiers in microbiology 74.0 25 Long non-coding RNAs in neurodegenerative diseases - Molecular mechanisms, liquid biopsy biomarkers, and therapeutic targets: A review. Biomolecules & biomedicine 84.0 26 Neurosyphilis and Parkinsonism: Overlapping Pathophysiology and Emerging Therapeutic Insights. Current neurovascular research 76.0 27 Molecular biochemistry of soluble epoxide hydrolase in lipid mediator pathways and neuroinflammatory responses. The Journal of steroid biochemistry and molecular biology 82.0 28 Multifaceted role of CNPY2 beyond ER stress: Disease implications and therapeutic potential. Cell stress 83.3 29 Neuroprotective Role of Exercise-based Physiotherapy Combined with Pharmacological Agents in Parkinson's Disease. Central nervous system agents in medicinal chemistry 64.0 30 Distinct metabolomic and proteomic signatures in Parkinson's disease patients with REM sleep behavior disorder. Signal transduction and targeted therapy 84.0 31 HMGB1-mediated neuroinflammation: molecular mechanisms and emerging therapeutic approaches. Inflammopharmacology 78.0 32 Beyond acid-base dyshomeostasis: Dynamic instability of neuronal lysosomal pH as a pathogenic mechanism and therapeutic target in neurological diseases. Biochemical pharmacology 88.0
Neurocompute Parkinson’s Narrative Velocity Infographic
NEUROCOMPUTE VISUAL SYSTEM

Open the Narrative Velocity Map

Explore the full Parkinson’s research intelligence diagram.

Expand Intelligence View →
Full Neurocompute Infographic